Therapeutic Advances in Gastrointestinal Endoscopy
Journal Highlights
- Re-launched in 2019
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Listed in PubMed and indexed in Web of Science and Emerging Sources Citation Index (ESCI)
- A leading gold open access journal in gastrointestinal endoscopy
- Reaches a broad, multidisciplinary audience
Therapeutic Advances in Gastrointestinal Endoscopy is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of gastrointestinal endoscopy with a strong focus on diagnostic and therapeutic advances. Please see the Aims and Scope tab for further information.
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Gastrointestinal Endoscopy promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the gastroenterology community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at https://mc.manuscriptcentral.com/cmg
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
The APC for this journal is currently 2650 USD. The article processing charge for Plain Language Summary is 4500 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any queries to Sophie.maprayil@sagepub.co.uk
Therapeutic Advances in Gastrointestinal Endoscopy is an open-access, peer-reviewed journal delivering the highest quality original research articles, reviews, and scholarly comments on pioneering efforts and innovative studies across all areas of gastrointestinal endoscopy with a strong focus on diagnostic and therapeutic advances. The journal is aimed at an international audience of endoscopists, clinicians, surgeons and researchers in endoscopy and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.
Review articles include expert opinion/perspective reviews, narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; a first editorial decision is generally reached within 3 weeks of Acceptance.
Abraham (Rami) Eliakim | Sheba Medical Center, Tel Hashomer, Israel |
Jemima Williamson | SAGE Publishing, London, UK |
Robert Benamouzig | Hôpital Avicenne, Bobigny, France |
Cesare Hassan | Nuovo Regina Margherita Hospital, Rome, Italy |
Uri Kopylov | Sheba Medical Center, Tel Hashomer, Israel |
Mark McAlindon | Royal Hallamshire Hospital, Sheffield, UK |
Cristiano Spada | Fondazione Poliambulanza, Brescia and Catholic University, Italy |
Pradeep Bhandari | Queen Alexandra Hospital, Portsmouth, UK |
Ivo Boškoski | Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy |
Guido Costamagna | Università Cattolica del Sacro Cuore, Roma, Italy |
José Cotter | University of Minho, Braga, Portugal |
Madhav Desai | University of Kansas Medical Center, Kansas City, Kansas, USA |
Simon M. Everett | Spire Leeds Hospital, Leeds,UK |
Ian Gralnek | Emek Medical Center, Afula, Israel |
Tomas Hucl | Institute for Clinical and Experimental Medicine, Prague, Czech Republic |
Martin Keuchel | University of Hamburg, Hamburg Germany |
Anastasios Koulaouzidis | University of Southern Denmark, Denmark |
Gianpiero Manes | G. Salvini Hospital, Milano, Italy |
Sara Monteiro | Alto Ave Hospital Center Creixomil, Guimarães, Portugal |
Helmut Neumann | University Medical Center Mainz, Mainz, Germany |
Kofi Oppong | Freeman Hospital, Newcastle upon Tyne, UK |
Oliver Pech | Krankenhaus Barmherzige Brüder, Regensburg, Germany |
Marco Pennazio | San Giovanni Battista University Teaching Hospital, Turin, Italy |
Jan-Werner Poley | Erasmus MC, University Medical Center Rotterdam, The Netherlands |
Gabriel Rahmi | Hôpital Européen Georges Pompidou, Paris, France |
Jaroslaw Regula | Institute of Oncology,Warsaw, Poland |
Douglas-Kevin Rex | University Hospital, Indianapolis (IN), USA |
Konstantinos Triantafyllou | University General Hospital, Athens, Greece |
Diana Yung | The Royal Infirmary of Edinburgh, Edinburgh, UK |